Our ambitious set of Health for Humanity 2025 Goals align to our ESG focus areas and foundation of accountability and innovation, and is how we hold ourselves publicly accountable in creating a more sustainable society. We measure and track performance against our Goals, with progress assured by a third party. Through our Health for Humanity 2025 Goals, we support 11 of the 17 UN SDGs.
Scorecard At-A-Glance
Progress is defined by the following categories:
Exceeded:
Exceeded target
Achieved:
Met target
On track:
Expected to meet target by 2025 or 2030
Some progress:
Progressing more slowly than expected —plans are in place to meet target by 2025 or 2030
Off track
Not progressing as expected—currently at risk of not meeting target by 2025 or 2030
Goal
Key Performance Indicator
Target
2022 Status
Global health equity
Global Access Plans
Key Performance Indicator:
% of identified assets from Johnson & Johnson Global Public Health and Janssen Infectious Diseases & Vaccines R&D pipeline with global access plans in place by 2025.
Target:
100%
2022 Status:
On track
Access to Tuberculosis (TB) Treatment
Key Performance Indicator:
# of cumulative patients receiving access to bedaquiline molecule (branded and generic) globally from 2021 through to end of 2025.
Target:
700,000
2022 Status:
On track
Developing TB Treatment
Key Performance Indicator:
Stringent regulatory authority approval of a new TB drug/regimen that reduces treatment length and is at least as effective and safe as the current recommended treatment by 2030.
Target:
New TB drug/regimen
2022 Status:
On track
Access to Schizophrenia Treatment
Key Performance Indicator:
Complete a clinical study to demonstrate the health, economic and social value of using paliperidone palmitate LAI to treat schizophrenia in Rwanda by 2024.
Target:
Complete clinical study
2022 Status:
On track
Support Frontline Health Workers
Key Performance Indicator:
# of nurses, midwives and community health workers reached globally.
Target:
1,000,000
2022 Status:
Exceeded
Reduce Burden of Obstetric Fistula
Key Performance Indicator:
# of fistula repair surgeries (based on surgeries reported or product donated).
Target:
10,000
2022 Status:
On track
Preventive Viral Vaccine Capabilities
Key Performance Indicator:
Create playbook including Documented Organizational Readiness for Pandemic Preparedness based on the demonstrated accelerated process for emergency use licensure submission of our COVID-19 vaccine.
Target:
Create playbook
2022 Status:
On track
Vaccination Monitoring Platform
Key Performance Indicator:
Adoption of endorsed platform by at least two countries by 2025.
Target:
Two countries
2022 Status:
On track
Healthcare for Women
Key Performance Indicator:
Three best-practice healthcare for women insights published.
Target:
Three
2022 Status:
Exceeded
Our employees
Women in Management
Key Performance Indicator:
% of women in management positions.
Target:
50%
2022 Status:
On track
Ethnic/Racial Diversity in Management
Key Performance Indicator:
% of ethnic/racial diversity in management positions in the U.S.
Target:
35%
2022 Status:
Achieved
Black/African Americans in Management
Key Performance Indicator:
% of Black and African American employees in management positions in the U.S.
Target:
50% growth from 2020
2022 Status:
On track
Healthiest Workforce Score
Key Performance Indicator:
% of Johnson & Johnson leaders and their managers achieving ≥80% annual Healthiest Workforce Score.
Target:
80% of leaders and their managers
2022 Status:
On track
Women in STEM2D
Key Performance Indicator:
# of girls who have participated in virtual or in-person activities led by employees in partnership with nonprofit partners.
Target:
2,000,000
2022 Status:
Some progress
Environmental health
Renewable Electricity
Key Performance Indicator:
% renewable electricity globally.
Target:
100%
2022 Status:
On track
Carbon Neutrality for Our Operations
Key Performance Indicator:
% absolute reduction in greenhouse gas (GHG) emissions – Scope 1 + 2 + carbon credits vs. 2016 baseline.
Target:
100%
2022 Status:
On track
Scope 3 Emissions Reductions
Key Performance Indicator:
% absolute reduction in greenhouse gas (GHG) emissions – Scope 3 (upstream) vs. 2016 baseline.
Target:
20%
2022 Status:
Some progress
Accountability & innovation
Supplier Sustainability Program
Key Performance Indicator:
All suppliers included in one of the three Tiers.
Target:
All suppliers
2022 Status:
On track
Global Supplier Diversity and Inclusion
Key Performance Indicator:
Spend with Tier 1 small and diverse suppliers, social enterprise and Tier 2 supplier spend.
Target:
$4.5 billion
2022 Status:
Exceeded
Partnerships for Good
Key Performance Indicator:
# of supplier partnerships.
Target:
10
2022 Status:
On track
ESG
Environmental, social and governance
HIV
Human immunodeficiency virus
LAI
Long-acting injectable
RLS
Resource-limited settings
SDG
Sustainable Development Goal (of the United Nations)
